Long-term safety of monthly zoledronic acid therapy beyond...

  • Main
  • 2017 / 01
  • Long-term safety of monthly zoledronic acid therapy beyond...

Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study

Khalafallah, A.A., Slancar, M., Cosolo, W., Abdi, E., Chern, B., Woodfield, R.J., Copeman, M.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
European Journal of Cancer Care
DOI:
10.1111/ecc.12638
Date:
January, 2017
File:
PDF, 360 KB
english, 2017
Conversion to is in progress
Conversion to is failed